Journal article · 2020 · Open access

T45. THE EFFICACY AND HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA: A META-ANALYSIS

Robert Ali McCutcheon, Toby Pillinger, Yuya Mizuno, Adam Montgomery, Haridha Pandian, Luke James Vano, Tiago Reis Marques, Oliver David Howes

Schizophrenia Bulletin, 46(Supplement_1), S248–S249 · Published 1 April 2020 · DOI 10.1093/schbul/sbaa029.605

Open full textCite this paper

In brief

“T45. THE EFFICACY AND HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA: A META-ANALYSIS” is a 2020 journal article by Robert Ali McCutcheon and 7 co-authors, published in Schizophrenia Bulletin. OpenAlex counts 3 citations as of 20 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Schizophrenia Bulletin.

Citations
3
Most cited in
2020 (1)
Authors
8

Abstract

Background Antipsychotics are more effective than placebo in reducing symptoms in schizophrenia. However, response to treatment appears to vary, and as such it has been proposed that different subtypes of schizophrenia exist, defined by treatment-response. This has not been formally examined using meta-analysis. Methods Randomised controlled trials comparing placebo and antipsychotics for the acute treatment of schizophrenia published between January 1 1950 and November 30, 2018 were examined. Mean change and variance of change in symptoms were extracted from each study, alongside publication year, participant age and gender, baseline symptom severity, antipsychotic dose, and use of placebo lead-in. Relative variability of symptomatic improvement in antipsychotic-treated individuals compared to placebo-treated individuals was quantified using coefficient of variation ratio (CVR). Mean difference in symptom change was quantified using Hedges’ g. The significance of potential moderating factors was assessed using meta-regression and sensitivity analyses. In addition, individual patient data from two clinical trials (N=522) was examined in terms of both the distribution of total symptom change, and the variability of individual symptoms and symptom factors. Results 11,006 articles were identified. 66 met inclusion criteria, reporting on 17,202 participants. Compared with placebo, antipsychotic-treated patients demonstrated both greater symptomatic improvement (g=0.47, p<0.001) and reduced variability in symptomatic improvement (CVR=0.86, p<0.001). Lower variability in antipsychotic-response was associated with studies including younger patients (z=3.07, p=0.002), those published earlier (z=3.98, p<0.001), with higher dose treatments (z=-2.62, p=0.009), and greater mean-difference in symptom-change (z=-5.70, p<0.001). In the individual patient data antipsychotic treated patients did not show significantly increased variability for any individual symptom, and there was no evidence of a bimodal distribution of response. Discussion Compared to placebo, in addition to a greater mean change, antipsychotic treatment shows lower variability of change in total, positive, and negative symptoms. This is contrary to the hypothesis that there exists a subtype of antipsychotic non-responsive schizophrenia, instead providing evidence for a relatively homogeneous effect of antipsychotic treatment in improving symptoms of schizophrenia.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

McCutcheon, R. A., Pillinger, T., Mizuno, Y., Montgomery, A., Pandian, H., Vano, L. J., Marques, T. R., & Howes, O. D. (2020). T45. THE EFFICACY AND HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA: A META-ANALYSIS. Schizophrenia Bulletin, 46(Supplement_1), S248–S249. https://doi.org/10.1093/schbul/sbaa029.605

MLA 9

McCutcheon, Robert Ali, et al. “T45. THE EFFICACY AND HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA: A META-ANALYSIS.” Schizophrenia Bulletin, vol. 46, no. Supplement_1, 2020, pp. S248–S249. https://doi.org/10.1093/schbul/sbaa029.605.

Chicago

McCutcheon, Robert Ali, Toby Pillinger, Yuya Mizuno, Adam Montgomery, Haridha Pandian, Luke James Vano, Tiago Reis Marques, and Oliver David Howes. 2020. “T45. THE EFFICACY AND HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA: A META-ANALYSIS.” Schizophrenia Bulletin 46 (Supplement_1): S248–S249. https://doi.org/10.1093/schbul/sbaa029.605.

Harvard

McCutcheon, R. A. et al. (2020) ‘T45. THE EFFICACY AND HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA: A META-ANALYSIS’, Schizophrenia Bulletin, 46(Supplement_1), pp. S248–S249. doi:10.1093/schbul/sbaa029.605.

IEEE

R. A. McCutcheon et al., “T45. THE EFFICACY AND HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA: A META-ANALYSIS,” Schizophrenia Bulletin, vol. 46, no. Supplement_1, pp. S248–S249, 2020, doi: 10.1093/schbul/sbaa029.605.

BibTeX

@article{mccutcheon2020efficacy,
  title     = {{T45. THE EFFICACY AND HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA: A META-ANALYSIS}},
  author    = {McCutcheon, Robert Ali and Pillinger, Toby and Mizuno, Yuya and Montgomery, Adam and Pandian, Haridha and Vano, Luke James and Marques, Tiago Reis and Howes, Oliver David},
  journal   = {Schizophrenia Bulletin},
  year      = {2020},
  volume    = {46},
  number    = {Supplement_1},
  pages     = {S248--S249},
  doi       = {10.1093/schbul/sbaa029.605},
  url       = {https://doi.org/10.1093/schbul/sbaa029.605}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202011
202111
202211

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • schizophrenia
  • antipsychotic drugs

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

McCutcheon, R. A., Pillinger, T., Mizuno, Y., Montgomery, A., Pandian, H., Vano, L. J., Marques, T. R., & Howes, O. D. (2020). T45. THE EFFICACY AND HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA: A META-ANALYSIS. Schizophrenia Bulletin, 46(Supplement_1), S248–S249. https://doi.org/10.1093/schbul/sbaa029.605

How many times has this paper been cited?

3 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Schizophrenia Bulletin: sign in and open the full text from this page.

Who wrote this paper?

Robert Ali McCutcheon, Toby Pillinger, Yuya Mizuno, Adam Montgomery, Haridha Pandian, Luke James Vano, Tiago Reis Marques, Oliver David Howes.

What is the DOI of this paper?

10.1093/schbul/sbaa029.605, permanently at https://doi.org/10.1093/schbul/sbaa029.605. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.